Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Shenhong Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants & Projects
- 19 Finished
-
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Keresztes, R. (PI), Wu, S. (CoPI), Choi, M. (CoPI), Kudelka, A. (CoPI) & Zhang, Y. (CoPI)
06/20/17 → 03/8/18
Project: Research
-
Genentech: Phase III, Multicenter, Randomized, Placebo-Controlled Double-Blind Study of Atezoluzumab (Anti-PD-L1 Antibody) as Adjuvant Therapy in Patients With Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy
Wu, S. (CoPI), Fitzgerald, J. (PI) & Zhang, Y. (CoPI)
05/11/17 → 03/22/19
Project: Research
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients with Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After...
Wu, S. (PI), Keresztes, R. (CoPI) & Kudelka, A. (CoPI)
12/28/15 → 10/26/18
Project: Research
-
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Darras, F. (CoPI), Waltzer, W. (CoPI), Wu, S. (CoPI), Corcoran, A. (PI), Fitzgerald, J. (CoPI) & Mishail, A. (CoPI)
08/18/14 → 06/10/16
Project: Research
-
ARGOS: An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
Adler, H. (CoPI), Darras, F. (CoPI), Waltzer, W. (CoPI), Wu, S. (CoPI), Corcoran, A. (PI), Fitzgerald, J. (CoPI), Galanakis, D. (CoPI) & Mishail, A. (CoPI)
08/15/14 → 04/2/17
Project: Research
-
Increased Risk of Hyperglycemia in Advanced Urothelial Cancer Patients Treated with Enfortumab Vedotin: A Systematic Review and Meta-Analysis
Cheng, R., Boparai, M., Zhu, X. & Wu, S., 2025, In: Cancer Investigation. 43, 5, p. 293-304 12 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
Nocco, S., Andriano, T. M., Bose, A., Chilov, M., Godwin, K., Dranitsaris, G., Wu, S., Lacouture, M. E., Roeker, L. E., Mato, A. R. & Markova, A., Jun 2022, In: Critical Reviews in Oncology/Hematology. 174, 103696.Research output: Contribution to journal › Review article › peer-review
20 Scopus citations -
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
Zhu, X. & Wu, S., Dec 2022, In: Clinical Hypertension. 28, 1, 14.Research output: Contribution to journal › Review article › peer-review
Open Access16 Scopus citations -
The Utility of 24-h Ambulatory Blood Pressure Monitoring for the Diagnosis and Management of White Coat Hypertension in a Primary Care Setting
Zhu, X., Hwu, I., Jacabacci, S. & Wu, S., 2022, In: Journal of Primary Care and Community Health. 13Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Fatal Adverse Events Associated with Pembrolizumab in Cancer Patients: A Meta-Analysis
Sher, A. F., Golshani, G. M. & Wu, S., Feb 7 2020, In: Cancer Investigation. 38, 2, p. 130-138 9 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations